Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Earth Science Tech, Inc. stock logo
ETST
Earth Science Tech
$0.20
-2.5%
$0.16
$0.00
$0.31
$57.39M1.85124,479 shs156,434 shs
EOM Pharmaceutical Holdings, Inc. stock logo
IMUC
EOM Pharmaceutical
$0.07
$0.10
$0.01
$0.21
$8.99M-0.01459 shsN/A
Innovus Pharmaceuticals Inc stock logo
INNVD
Innovus Pharmaceuticals
$0.00
$1.50
$19.37
$7.07M2.899,592 shs4,300 shs
NSPX
Inspyr Therapeutics
$0.00
$0.00
$0.07
$1.47M-17.3313.19 million shs29.64 million shs
Cortex Pharmaceuticals Inc. stock logo
RSPI
Cortex Pharmaceuticals
$0.00
-11.1%
$0.00
$0.00
$0.00
$760K0.14446,295 shs5,000 shs
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Earth Science Tech, Inc. stock logo
ETST
Earth Science Tech
0.00%+2.63%+30.00%+42.13%-25.00%
EOM Pharmaceutical Holdings, Inc. stock logo
IMUC
EOM Pharmaceutical
0.00%+5.96%+14.31%-53.83%-58.18%
Innovus Pharmaceuticals Inc stock logo
INNVD
Innovus Pharmaceuticals
0.00%0.00%0.00%0.00%0.00%
NSPX
Inspyr Therapeutics
0.00%0.00%0.00%0.00%0.00%
Cortex Pharmaceuticals Inc. stock logo
RSPI
Cortex Pharmaceuticals
0.00%+33.33%-55.56%-65.22%-66.67%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Earth Science Tech, Inc. stock logo
ETST
Earth Science Tech
N/AN/AN/AN/AN/AN/AN/AN/A
EOM Pharmaceutical Holdings, Inc. stock logo
IMUC
EOM Pharmaceutical
N/AN/AN/AN/AN/AN/AN/AN/A
Innovus Pharmaceuticals Inc stock logo
INNVD
Innovus Pharmaceuticals
N/AN/AN/AN/AN/AN/AN/AN/A
NSPX
Inspyr Therapeutics
N/AN/AN/AN/AN/AN/AN/AN/A
Cortex Pharmaceuticals Inc. stock logo
RSPI
Cortex Pharmaceuticals
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Earth Science Tech, Inc. stock logo
ETST
Earth Science Tech
0.00
N/AN/AN/A
EOM Pharmaceutical Holdings, Inc. stock logo
IMUC
EOM Pharmaceutical
0.00
N/AN/AN/A
Innovus Pharmaceuticals Inc stock logo
INNVD
Innovus Pharmaceuticals
0.00
N/AN/AN/A
NSPX
Inspyr Therapeutics
0.00
N/AN/AN/A
Cortex Pharmaceuticals Inc. stock logo
RSPI
Cortex Pharmaceuticals
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Earth Science Tech, Inc. stock logo
ETST
Earth Science Tech
$33.12M1.73$0.01 per share16.85N/A
EOM Pharmaceutical Holdings, Inc. stock logo
IMUC
EOM Pharmaceutical
N/AN/AN/AN/AN/AN/A
Innovus Pharmaceuticals Inc stock logo
INNVD
Innovus Pharmaceuticals
$23.99M0.00N/AN/A$0.05 per share0.00
NSPX
Inspyr Therapeutics
N/AN/AN/AN/A($0.07) per shareN/A
Cortex Pharmaceuticals Inc. stock logo
RSPI
Cortex Pharmaceuticals
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Earth Science Tech, Inc. stock logo
ETST
Earth Science Tech
$3.25MN/A0.00N/A9.82%101.18%62.84%N/A
EOM Pharmaceutical Holdings, Inc. stock logo
IMUC
EOM Pharmaceutical
-$1.89MN/A0.00N/AN/AN/AN/AN/A
Innovus Pharmaceuticals Inc stock logo
INNVD
Innovus Pharmaceuticals
-$8.28M-$4.16N/A0.00N/A-34.51%-682.54%-78.57%N/A
NSPX
Inspyr Therapeutics
-$6.30MN/A0.00N/AN/AN/AN/A-1,354.49%N/A
Cortex Pharmaceuticals Inc. stock logo
RSPI
Cortex Pharmaceuticals
-$2.10MN/A0.00N/AN/AN/AN/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Earth Science Tech, Inc. stock logo
ETST
Earth Science Tech
N/AN/AN/AN/AN/A
EOM Pharmaceutical Holdings, Inc. stock logo
IMUC
EOM Pharmaceutical
N/AN/AN/AN/AN/A
Innovus Pharmaceuticals Inc stock logo
INNVD
Innovus Pharmaceuticals
N/AN/AN/AN/AN/A
NSPX
Inspyr Therapeutics
N/AN/AN/AN/AN/A
Cortex Pharmaceuticals Inc. stock logo
RSPI
Cortex Pharmaceuticals
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Earth Science Tech, Inc. stock logo
ETST
Earth Science Tech
0.01
0.87
0.81
EOM Pharmaceutical Holdings, Inc. stock logo
IMUC
EOM Pharmaceutical
N/AN/AN/A
Innovus Pharmaceuticals Inc stock logo
INNVD
Innovus Pharmaceuticals
N/A
0.68
0.36
NSPX
Inspyr Therapeutics
N/A
0.09
0.09
Cortex Pharmaceuticals Inc. stock logo
RSPI
Cortex Pharmaceuticals
N/AN/AN/A
CompanyEmployeesShares OutstandingFree FloatOptionable
Earth Science Tech, Inc. stock logo
ETST
Earth Science Tech
3294.30 million221.02 millionNot Optionable
EOM Pharmaceutical Holdings, Inc. stock logo
IMUC
EOM Pharmaceutical
3126.50 million122.35 millionNot Optionable
Innovus Pharmaceuticals Inc stock logo
INNVD
Innovus Pharmaceuticals
122.36 millionN/ANot Optionable
NSPX
Inspyr Therapeutics
1543.15 millionN/ANot Optionable
Cortex Pharmaceuticals Inc. stock logo
RSPI
Cortex Pharmaceuticals
2949.46 million474.45 millionNot Optionable

Recent News About These Companies

RespireRx Pharmaceuticals Inc (RSPI)
RespireRx Pharmaceuticals Inc RSPI
RCKT Rocket Pharmaceuticals, Inc.
Other OTC Pharmaceuticals - Haiti
Other OTC Pharmaceuticals - Vietnam
Other OTC Pharmaceuticals - Finland
Alnylam Pharmaceuticals (NASDAQ: ALNY)

New MarketBeat Followers Over Time

Media Sentiment Over Time

Earth Science Tech stock logo

Earth Science Tech OTCMKTS:ETST

$0.20 -0.01 (-2.50%)
As of 07/3/2025 12:48 PM Eastern

Earth Science Tech, Inc. focuses on health and wellness industry. It operates men's health telemedicine platform under brand Peak name; and operates pharmacy. The company offers supplements and topicals products. The company was formerly known as Ultimate Novelty Sports, Inc. and changed its name to Earth Science Tech, Inc. in March 2014. Earth Science Tech, Inc. was incorporated in 2010 and is headquartered in Miami, Florida.

EOM Pharmaceutical stock logo

EOM Pharmaceutical OTCMKTS:IMUC

$0.07 0.00 (0.00%)
As of 07/3/2025

Immunocellular Therapeutics, Ltd., a clinical-stage pharmaceutical company, focuses on the development of therapeutics and delivery technologies for the treatment of inflammatory conditions and ocular diseases. Its lead clinical asset is EOM613 solution, a peptide nucleic-acid solution with anti-inflammatory and pro-inflammatory effects on cytokines and chemokines for the treatment of cancer cachexia and rheumatoid arthritis. The company also develops EOM 147, an investigational, broad-spectrum aminosterol with an intracellular mechanism for the treatment of chronic and debilitating retinal diseases. Immunocellular Therapeutics, Ltd. was founded in 2020 and is headquartered in Montvale, New Jersey.

Innovus Pharmaceuticals stock logo

Innovus Pharmaceuticals OTCMKTS:INNVD

Innovus Pharmaceuticals, Inc., a pharmaceutical company, engages in the development, licensing, and commercialization of non-prescription medicines and consumer care products in the United States. Its products include Zestra, a proprietary blend of essential oils to enhance desire, arousal, and satisfaction in women; EjectDelay, an over-the-counter monograph compliant benzocaine gel for premature ejaculation; Sensum+, a non-medicated cream for penile sensitivity; Zestra Glide, a water-based longer lasting lubricant; Vesele, a proprietary oral supplement for promoting sexual health; and Androferti, a natural supplement to support male reproductive health and sperm quality. The company also offers Beyond Human testosterone booster, ketones, krill oil, omega 3 fish oil, Vision Formula, blood sugar, colon cleanse, green coffee extract, and growth agent; RecalMax for brain health; UriVarx, a supplement for overactive bladder and urinary incontinence; PEVarx, a supplement for peak sexual performance; ProstaGorx, a supplement for prostate support; and FlutiCare, a nasal spray. In addition, its products include Apeaz for pain relief; AllerVarx for allergy relief; ArthriVarx for joint pain; Xyralid, a hemorrhoid cream; Can-C eye drop and eye care capsule; MZS, a melatonin formula to enhance sleep patterns; and Diabasens, a diabetic foot cream. The company's pipeline products comprise UriVarx for urinary tract infection; Xyralid suppositories for hemorrhoidal symptoms; GlucoGorx supplement, glucometer, lancing device, and GlucoGorx strip for blood sugar levels; Vesele and RecalMax nitric oxide strips. It markets and sells its products through commercial partners to primary care physicians, urologists, gynecologists, and therapists, as well as to other healthcare providers; and directly to consumers through online channels, retailers, and wholesalers. Innovus Pharmaceuticals, Inc. was founded in 2008 and is headquartered in San Diego, California.

Inspyr Therapeutics OTCMKTS:NSPX

Inspyr Therapeutics, Inc. is a pharmaceutical company, which engages in the research and development of novel therapeutics for the treatment of cancer. Its product pipeline includes Mipsagargin, a dual A2A/A2B antagonist, an A2A antagonist, an A2B antagonist, and an A2A agonist. The company was founded by Craig A. Dionne, John T. Issacs, and Samuel R. Denmeade on November 21, 2003 and is headquartered in Westlake Village, CA.

Cortex Pharmaceuticals stock logo

Cortex Pharmaceuticals OTCMKTS:RSPI

$0.0008 0.00 (-11.11%)
As of 07/3/2025 12:38 PM Eastern

RespireRx Pharmaceuticals Inc. engages in the discovery, development, and commercialization of pharmaceuticals for the treatment of neurological and psychiatric disorders. It has two drug platforms comprising ResolutionRx, a pharmaceutical cannabinoids platform, which includes dronabinol that acts upon the CB1 and CB2 endocannabinoid receptors for use in chemotherapy-induced nausea and vomiting, as well as for anorexia in patients with AIDS and obstructive sleep apnea; and EndeavourRx, a neuromodulators platform that comprises AMPAkines program, including proprietary compounds that are positive allosteric modulators (PAMs) of glutamate receptors to promote neuronal function, and GABAkines program, including proprietary compounds that are PAMs of GABAA receptors. The company's lead ampakine, CX1739, which has completed Phase II clinical studies for opioid-induced respiratory depression, as well as for central sleep apnea. It is also developing CX717, CX1739, and CX1942 that have clinical application in the treatment of CNS-driven neurobehavioral and cognitive disorders, spinal cord injury, neurological diseases, and various orphan indications. It has a research collaboration with University College London to the use of AMPAkines for the treatment of GRIA disorders. The company was formerly known as Cortex Pharmaceuticals, Inc. and changed its name to RespireRx Pharmaceuticals Inc. in December 2015. RespireRx Pharmaceuticals Inc. was incorporated in 1987 and is headquartered in Glen Rock, New Jersey.